MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacasi.2026.01.034

Медицинская библиотека · JACC. Asia · 2026

Transcatheter Aortic Valve Replacement for Failed Small Surgical Bioprostheses.

Kamioka Norihiko, Ohno Yohei, Otsuka Toshiaki, Tada Norio, Naganuma Toru, Yamawaki Masahiro, Yamanaka Futoshi, Shirai Shinichi, Nakazawa Gaku, Noguchi Masahiko, Ueno Hiroshi, Takagi Kensuke, Izumo Masaki, Nishina Hidetaka, Suzuyama Hiroto, Yamasaki Kazumasa, Nishioka Kenji, Hachinohe Daisuke, Fuku Yasushi, Yashima Fumiaki, Asami Masahiko, Watanabe Yusuke, Yamamoto Masanori, Hayashida Kentaro, OCEAN-TAVI Investigators

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Data on the prognostic impact of failed surgical bioprosthetic size following valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) remain limited.

OBJECTIVES

This study aimed to assess the impact of failed bioprosthetic size and subsequent prosthesis-patient mismatch (PPM) on midterm outcomes of ViV TAVR.

METHODS

We analyzed patients who underwent ViV TAVR for degenerated surgical bioprostheses in the OCEAN-TAVI (Optimized transCathEter vAlvular iNtervention-transcatheter aortic valve implantation) registry. Patients were divided into 2 groups according to the true internal diameter (ID) of bioprostheses: the small bioprosthesis (SB) group (ID ≤20 mm) and the non-small bioprosthesis (NB) group (ID >20 mm). The primary endpoint was a composite of cardiovascular death or heart failure hospitalization at 3 years. Factors associated with severe measured PPM were also examined.

RESULTS

Among 367 consecutive patients undergoing ViV TAVR (244 patients in the SB group vs 123 patients in the NB group), 30-day mortality was 0.5%. Severe PPM occurred in 16.9% of the entire cohort and was more prevalent in the SB group (21.3% in the SB group vs 8.3% in the NB group; P = 0.001). The SB group had a higher risk of cardiovascular death or heart failure hospitalization at 3 years (19.1% in the SB group vs 9.8% in the NB group; adjusted HR: 3.48; 95% CI: 1.11-10.87). The SB patients with severe PPM had the highest risk of the primary outcome at 3 years (SB with PPM 39.2% vs NB without PPM 11.0%; adjusted HR: 6.65 [95% CI: 1.95-22.71] compared with the NB group without PPM). Factors associated with severe PPM included larger body surface area, balloon-expandable valve implantation, and true ID ≤20 mm.

CONCLUSIONS

ViV TAVR for small surgical bioprostheses was associated with worse clinical outcome, particularly in those with severe PPM. (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation [OCEAN-TAVI]; UMIN000020423).

Для цитирования: Kamioka Norihiko, Ohno Yohei, Otsuka Toshiaki, Tada Norio, Naganuma Toru, Yamawaki Masahiro, Yamanaka Futoshi, Shirai Shinichi, Nakazawa Gaku, Noguchi Masahiko, Ueno Hiroshi, Takagi Kensuke, Izumo Masaki, Nishina Hidetaka, Suzuyama Hiroto, Yamasaki Kazumasa, Nishioka Kenji, Hachinohe Daisuke, Fuku Yasushi, Yashima Fumiaki, Asami Masahiko, Watanabe Yusuke, Yamamoto Masanori, Hayashida Kentaro, OCEAN-TAVI Investigators. Transcatheter Aortic Valve Replacement for Failed Small Surgical Bioprostheses.. JACC. Asia. 2026. DOI: 10.1016/j.jacasi.2026.01.034.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.